Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study
Kwadwo Koram(University of Ghana), Francis Nkrumah(University of Cape Coast), Y. Karikari(University of Ghana), Susan Adu-Amankwah(University of Ghana), Michael Ntiri(University of Ghana), Karl Kronmann(Naval Medical Center Portsmouth), Benjamin Abuaku(University of Ghana), Ben Gyan(Stockholm University), Daniel Dodoo(Commonwealth Scientific and Industrial Research Organisation), Josephine Ocran(University of Ghana), Bright Adu(University of Ghana)
Cited by 26
Related Papers
Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria
|The Lancet|1998|329
Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on <i>Plasmodium falciparum</i> -Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A
|The Journal of Immunology|2000|305
Absolute Levels and Ratios of Proinflammatory and Anti‐inflammatory Cytokine Production In Vitro Predict Clinical Immunity to<i>Plasmodium falciparum</i>Malaria
|The Journal of Infectious Diseases|2002|245
Reappraisal of known malaria resistance loci in a large multicenter study
|Nature Genetics|2014|245
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans
|Nature Genetics|2007|222